Health

Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy

SUZHOU, China, Jan. 18, 2021 /PRNewswire/ -- Cure Genetics announced a collaboration with Boehringer Ingelheim to develop novel Adeno-Associated Virus (AAV) vectorsleveraging Cure Genetics' proprietary VELPTM platform to develop next-generation gene therapies. This new collaboration combines Boeh...

2021-01-18 22:00 2021

Regent Pacific Group Limited Announces the Successful Launch of Fortacin(TM) in Hong Kong, Upcoming Launches in Taiwan and Macau and Related Business Updates

HONG KONG, Jan. 18, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Fortacin™, the Group's ...

2021-01-18 21:21 10614

TenNor Enters Research Collaboration with Janssen for Potential New Treatments for Nontuberculous Mycobacteria Diseases

SUZHOU, China, Jan. 18, 2021 /PRNewswire/ -- TenNor Therapeutics (Suzhou) Limited, a clinical-stage biopharmaceutical company dedicated to research and development of differentiated products for the treatment of diseases associated with bacterial infections and dysbioses, announced today that it ...

2021-01-18 21:00 1381

Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy

BEDMINSTER, N.J. and SINGAPORE, Jan. 18, 2021 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced that the European Medicines Agency (EMA) has granted PRior...

2021-01-18 19:00 1784

New report from FDI World Dental Federation tackles oral health inequalities and outlines strategies to improve oral healthcare over the next ten years

·  Oral conditions such as tooth decay, gum disease, tooth loss and oral cancer are the most widespread noncommunicable diseases worldwide – impacting 3.5 billion people – and have severe and significant health, societal, and economic impacts. ·  Oral health professionals must be actively includ...

2021-01-18 19:00 2553

Everest Medicines Announces Amended Agreement with Spero Therapeutics

SHANGHAI, Jan. 18, 2021 /PRNewswire/ -- Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts ofAsia, today announced that under an amen...

2021-01-18 18:05 6243

ZhenMeiHui Self-healing Rejuvenation Technology Continues to Look Good Despite the Fast-changing Aesthetic Medicine Industry in China

SHANGHAI, Jan. 18, 2021 /PRNewswire/ -- On May 19, the iResearch Services, a firm of data research, released theWhite Paper on Insights into the Chinese Aesthetic Medicine Industry in 2020(hereinafter referred to as the "White Paper"). According to the document,China's aesthetic medicine market s...

2021-01-18 17:36 1266

DoctorOnCall Aid Relief For Flood Victims in Pahang with Free Telehealth and Medical Assistance Programme

KUALA LUMPUR, Malaysia, Jan. 18, 2021 /PRNewswire/ -- The State of Pahang has been badly affected by the recent torrential rain and is one of the hardest hit in Semenanjung Malaysia. DoctorOnCall,Malaysia's first and largest digital health platform, reached out to help lighten the burden of those...

2021-01-18 14:10 2463

MFine Raises $16m From New & Existing Investors Led by Heritas Capital as Adoption of Digital Health Soars in India Amidst COVID-19 Pandemic

SINGAPORE and BENGALURU, India, Jan. 18, 2021 /PRNewswire/ -- India's leading Digital Health startupMFine has raised $16m in a new funding round led byHeritas Capital with participation from Singapore-based family office of Y'S Investment Pte Ltd. Existing MFine investors ...

2021-01-18 13:00 1962

BookDoc - Reaching New Heights in 2020

KUALA LUMPUR, Malaysia, Jan. 18, 2021 /PRNewswire/ -- BookDoc is a health technology company headquartered inMalaysia which provides end-to-end digital solutions to healthcare. It is the only company inMalaysia and health technology company inAsia listed in the CNBC Upstart 100 List 2019, and cu...

2021-01-18 09:00 2844

StarMed Specialist Centre partners Prudential on the PRUPanel Connect Programme to deliver quality private healthcare experience for patients

SINGAPORE, Jan. 18, 2021 /PRNewswire/ -- StarMed Specialist Centre ("StarMed"), a private ambulatory care service provider under the HMI Group, has entered into a partnership with Prudential Singapore ("Prudential") as a preferred specialist healthcare and day surgery partner on the insurer's PRU...

2021-01-18 08:00 2650

CES 2021 MedFluid Develops First-In-Class Microfluidic Platform for Rapid Detection and Screening of Disease Diagnosis

TAIPEI, Taiwan, Jan. 17, 2021 /PRNewswire/ -- Health and Biotech company MedFluid has developed the fastest, first-in-class antimicrobial susceptibility test that will aid in providing precise medical prescriptions to improve the health and well-being of patients.

2021-01-17 18:02 1977

COVID-19 vaccines: Common solution, not competition

BEIJING, Jan. 15, 2021 /PRNewswire/ -- A news report by China.org.cn on China's COVID-19 vaccines:   At the end of 2020, one of China's self-developed COVID-19 vaccines was granted conditional approval for general use by the National Medical Products Administration. Previously,...

2021-01-15 22:01 4605

Senhwa Biosciences Presents Positive Cholangiocarcinoma Data

TAIPEI and SAN DIEGO, Jan. 15, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announces that promising clinical data from their global phase...

2021-01-15 22:00 2798

Gracell Biotechnologies Receives Medical Products Manufacturing Certificate for CAR-T Cell Therapy Products

SUZHOU, China, Jan. 15, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, has been granted the Medical Products Manuf...

2021-01-15 21:00 2821

Modern Chinese Medicine Group Co., Ltd. Trading Debut Closed at HK$1.26 Per Share

HONG KONG, Jan. 15, 2021 /PRNewswire/ -- Modern Chinese Medicine Group Co., Ltd. ("Modern Chinese Medicine", together with its subsidiaries, the "Group"; stock code: 1643), which principally engages in the production of proprietary Chinese medicine (the "PCM") and offers both over-the-counter (the...

2021-01-15 18:57 12933

CES 2021 Taiwanese Startup ACSI Gives New Technological Shine to Traditional Chinese Medical Treatments

TAIPEI, Jan. 15, 2021 /PRNewswire/ -- Chinese medicine has been receiving increased attention worldwide. These traditional therapeutic treatments are now being combined with modern technology and integrated into Western medicine. Acupuncture, for example, is being widely adopted and trusted by pa...

2021-01-15 14:35 1718

Air France Awarded 4-Star "COVID-19 Airline Safety Rating" By Skytrax

PARIS, Jan. 15, 2021 /PRNewswire/ -- Air France has been certified with the  COVID-19 Airline Safety Rating following the global audit conducted by the international air transport rating agency Skytrax. This audit, carried out in December 2020 on several Air France medium and long-haul flights, eva...

2021-01-15 12:24 2527

United Immunity and Xyphos, an Astellas Company, to Collaborate on Next Generation Nano-Immunotherapies for Cancer Treatment

TOKYO, Jan. 15, 2021 /PRNewswire/ -- United Immunity, Co., Ltd. (CEO, Naozumi Harada, Ph.D. Mie,Japan), a drug discovery biotech specializing in nanoparticle-based cancer immunotherapies (nano-immunotherapies), has entered into a joint research agreement as ofDecember 2020 with Xyphos Biosciences...

2021-01-15 10:00 3596

Hyde Engineering + Consulting Announces Appointment of Chief Executive Officer

Kerren Bergman Promoted to Lead Hyde's Global Corporation BOULDER, Colo., Jan. 15, 2021 /PRNewswire/ -- Hyde Engineering + Consulting, Inc. (Hyde) a worldwide partner for solution-based pharmaceutical design and consulting services, announced the appointment of Kerren Bergman as Chief Executive ...

2021-01-15 00:48 14041
1 ... 670671672673674675676 ... 858